Works matching IS 0007-0920 AND VI 132 AND IP 12 AND DT 2025

Results: 13

Retraction Note: Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells.

Published in:

British Journal of Cancer, 2025, v. 132, n. 12, p. 1200, doi. 10.1038/s41416-025-03036-y

By:

Liau, S-S;
Jazag, A;
Ito, K;
Whang, E E

Publication type:

Article

Optimal timing of cancer treatments: a call for emerging evidence from clinical trials and real-world studies.

Published in:

British Journal of Cancer, 2025, v. 132, n. 12, p. 1085, doi. 10.1038/s41416-025-03030-4

By:

Zhang, Jianrong;
Venchiarutti, Rebecca;
Wang, Xiaofei;
He, Qihua

Publication type:

Article

Anticancer effects of vitamin K combined with transarterial chemoembolization in hepatocellular carcinoma, a randomized controlled trial.

Published in:

British Journal of Cancer, 2025, v. 132, n. 12, p. 1141, doi. 10.1038/s41416-025-03022-4

By:

Haruna, Yoshimichi;
Yakushijin, Takayuki;
Yamakawa, Miho;
Nakazawa, Tetsuo

Publication type:

Article

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis.

Published in:

British Journal of Cancer, 2025, v. 132, n. 12, p. 1124, doi. 10.1038/s41416-025-03021-5

By:

Bloem, M.;
de Meza, M. M.;
van den Eertwegh, A. J. M.;
Aarts, M. J. B.;
van den Berkmortel, F. W. P. J.;
Blank, C. U.;
Blokx, W. A. M.;
Boers-Sonderen, M. J.;
Bonenkamp, J. J.;
Boreel, C. D. M.;
de Groot, J. W. B.;
Haanen, J. B. A. G.;
Hospers, G. A. P.;
Kapiteijn, E.;
van Not, O. J.;
Piersma, D.;
Rikhof, B.;
Stevense-den Boer, A. M.;
van der Veldt, A. A. M.;
Vreugdenhil, G.

Publication type:

Article

Tumor-stroma ratio combined with PD-L1 identifies pancreatic ductal adenocarcinoma patients at risk for lymph node metastases.

Published in:

British Journal of Cancer, 2025, v. 132, n. 12, p. 1131, doi. 10.1038/s41416-025-03019-z

By:

Chen, Xianlong;
Sun, Shanyue;
Zhao, Jiapeng;
Yu, Shuangni;
Chen, Jie;
Chen, Xinyuan

Publication type:

Article

Ovarian cancer survival by residual disease following cytoreductive surgery: a nationwide study in Norway.

Published in:

British Journal of Cancer, 2025, v. 132, n. 12, p. 1158, doi. 10.1038/s41416-025-03018-0

By:

Trewin-Nybråten, Cassia B.;
Leithe, Sigrid;
Paulsen, Torbjørn;
Langseth, Hilde;
Fortner, Renée Turzanski

Publication type:

Article

Peripheral blood neutrophils contribute to Claudin18.2-specific CAR-T cell treatment resistance in advanced gastric cancer.

Published in:

British Journal of Cancer, 2025, v. 132, n. 12, p. 1167, doi. 10.1038/s41416-025-03015-3

By:

Li, Jiarui;
Tao, Min;
Liu, Lian;
Liu, Chang;
Ma, Mingyang;
Liu, Dan;
Zhang, Panpan;
Zhang, Miao;
Xue, Ran;
Gong, Jifang;
Zhang, Cheng;
Zhang, Xiaotian;
Shen, Lin;
Qi, Changsong

Publication type:

Article

The organ-specific modulation of malignant processes by opioids: a systematic review of cell culture studies.

Published in:

British Journal of Cancer, 2025, v. 132, n. 12, p. 1091, doi. 10.1038/s41416-025-03014-4

By:

Hefteh, Natalia;
Welch, Olivia;
Sheikh, Mahdi;
La Caze, Adam;
Parat, Marie-Odile

Publication type:

Article

Single-cell profiling in ovarian germ cell and sex cord-stromal tumours.

Published in:

British Journal of Cancer, 2025, v. 132, n. 12, p. 1110, doi. 10.1038/s41416-025-03012-6

By:

Laga, T.;
Van Rompuy, AS;
Busschaert, P.;
Marquina, G.;
Loverix, L.;
Olbrecht, S.;
Ottenbourgs, T.;
Baert, T.;
Van Gorp, T.;
Vergote, I.;
Lambrechts, D.;
Van Nieuwenhuysen, E.

Publication type:

Article

Novel strategy to target glioblastoma-initiating cells using a braintropic adeno-associated virus carrying a miR-dependent genome-editing system.

Published in:

British Journal of Cancer, 2025, v. 132, n. 12, p. 1100, doi. 10.1038/s41416-025-03007-3

By:

Wang, Zhe;
Zou, Peilin;
Chen, Zhenzhong;
Hou, Jiahui;
Son, You Lee;
Yamashita, Daisuke;
Kondo, Toru

Publication type:

Article

Smad4 loss identifies aggressive subtype with immunotherapy and anti-HER-2 treatment resistance in gastric cancer.

Published in:

British Journal of Cancer, 2025, v. 132, n. 12, p. 1148, doi. 10.1038/s41416-025-03002-8

By:

Sun, Mengyao;
Gu, Yun;
Wang, Jieti;
Zhang, Ziqiu;
Ling, Zhen;
Shao, Fei;
Lin, Chao;
He, Hongyong;
Li, Ruochen;
Liu, Hao;
Xu, Jiejie

Publication type:

Article

Unveiling the BRAF fusion structure variations through DNA and RNA sequencing.

Published in:

British Journal of Cancer, 2025, v. 132, n. 12, p. 1177, doi. 10.1038/s41416-025-02998-3

By:

Yang, Qiong;
Wang, Baoming;
Meng, Xuli;
Ma, Tonghui;
Qian, Zhenyuan;
Cai, Xufan;
Sun, Xiaochen;
Xu, Yan;
Luo, Qifeng;
Yang, Tianyao;
Tao, Houquan;
Qian, Yangyang;
Shao, Jianzhong;
Ye, Zaiyuan

Publication type:

Article

Novel Skp1 inhibitor has potent preclinical efficacy against castration-resistant prostate cancer.

Published in:

British Journal of Cancer, 2025, v. 132, n. 12, p. 1188, doi. 10.1038/s41416-025-02993-8

By:

Li, Xin;
Mamouni, Kenza;
Zhao, Rui;
Bai, Lijuan;
Chen, Yanhua;
Wu, Yifei;
Xie, Zhong-Ru;
Sautto, Giuseppe A.;
Liu, Degang;
Bowen, Nathan J.;
Danaher, Alira;
Li, Dehong;
Cook, Nicholas;
Grayson, Skylar;
Zhu, Jedidiah;
Coleman, Ilsa M.;
Nelson, Peter S.;
Bao, Qichao;
Zhou, Jia;
Osunkoya, Adeboye O.

Publication type:

Article